journal article·2025-04-25Open access

The emerging era of structural nanomedicine

Chad A. Mirkin, Milan Mrksich, Natalie Artzi

Nature Reviews Bioengineering· Volume 3· Issue 7

Abstract

The lack of structural definition in nanomedicines limits therapeutic efficacy and complicates regulatory approval. Here, we emphasize that defining, designing and optimizing the structures of nanomedicine are critical to developing effective therapies because their architectures - not just the identity of their components - determines potency.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Advanced Biosensing Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (15)

Show source-provided references
1. Franks, M. E., Macpherson, G. R. & Figg, W. D. Thalidomide. Lancet 363, 1802–1811 (2004).10.1016/S0140-6736(04)16308-3 ↗
2. Evans, A. M. Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen. Clin. Rheumatol. 20, 9–14 (2001).10.1007/BF03342662 ↗
3. Mirkin, C. A., Letsinger, R. L., Mucic, R. C. & Storhoff, J. J. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382, 607–609 (1996).10.1038/382607a0 ↗
4. Mirkin, C. A. & Petrosko, S. H. Inspired beyond nature: three decades of spherical nucleic acids and colloidal crystal engineering with DNA. ACS Nano 17, 16291–16307 (2023).10.1021/acsnano.3c06564 ↗
5. Oliva, N., Conde, J., Wang, K. & Artzi, N. Designing hydrogels for on-demand therapy. Acc. Chem. Res. 50, 669–679 (2017).10.1021/acs.accounts.6b00536 ↗
6. Dosta, P. et al. Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles. Nat. Nanotechnol. 18, 1351–1363 (2023).10.1038/s41565-023-01447-7 ↗
7. Sridhar, S. et al. Synthesis and activity of T-cell tumor-directing megamolecules. J. Am. Chem. Soc. 146, 26801–26807 (2024).10.1021/jacs.4c07377 ↗
8. Yamankurt, G. et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat. Biomed. Eng. 3, 318–327 (2019).10.1038/s41551-019-0351-1 ↗
9. Teplensky, M. H. et al. Multi-antigen spherical nucleic acid cancer vaccines. Nat. Biomed. Eng. 7, 911–927 (2023).10.1038/s41551-022-01000-2 ↗
10. Veneziano, R. et al. Role of nanoscale antigen organization on B-cell activation probed using DNA origami. Nat. Nanotechnol. 15, 716–723 (2020).10.1038/s41565-020-0719-0 ↗
11. Ngo, K. H. et al. DNA dendron tagging as a universal way to deliver proteins to cells. J. Am. Chem. Soc. 147, 2129–2136 (2025).10.1021/jacs.4c16205 ↗
12. Li, H. et al. Molecular spherical nucleic acids. Proc. Natl Acad. Sci. USA 115, 4340–4344 (2018).10.1073/pnas.1801836115 ↗
13. Conde, J., Oliva, N. & Artzi, N. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. Proc. Natl Acad. Sci. USA 112, E1278–E1287 (2015).10.1073/pnas.1421229112 ↗
14. Winegar, P. H. et al. Modular nucleic acid scaffolds for synthesizing monodisperse and sequence-encoded antibody oligomers. Cell 8, 3018–3030 (2022).
15. Veneziano, R. et al. Designer nanoscale DNA assemblies programmed from the top down. Science 352, 1534 (2016).10.1126/science.aaf4388 ↗